Neuronetics, Inc.

medical devices

About

Neuronetics, Inc. is a neurotechnology company based in Malvern, Pennsylvania, founded in 2003. The company focuses on developing and marketing non-invasive neuromodulation treatments for psychiatric disorders, particularly treatment-resistant depression and obsessive-compulsive disorder (OCD). Its flagship product, the NeuroStar® Advanced Therapy system, is a transcranial magnetic stimulation (TMS) device that delivers targeted magnetic pulses to the brain. NeuroStar is the first FDA-cleared TMS therapy for major depressive disorder in adults who have not responded to other antidepressant medications and has also received clearance for treating OCD. Neuronetics also offers TrakStar, a cloud-based platform for data collection and analysis to enhance patient outcomes. With a commitment to improving the quality of life for individuals with psychiatric disorders, Neuronetics has performed over 7.6 million NeuroStar treatments worldwide. The company emphasizes a patient-centric approach and provides extensive support to healthcare providers, making it a leader in the TMS industry.

Technologies

Outlook Microsoft Office 365 Remote

Keywords

tms therapy & transcranial magnetic stimulation medical/dental instruments health care medical equipment manufacturing ocd treatment brain connectivity medical equipment and supplies manufacturing clinical trials safety profile depression treatment long-term remission treatment efficacy focused magnetic pulses fda cleared services brain synapses patient care ocd therapy synapse reactivation real-world outcomes tms device precision coil placement neurostimulation outcomes registry outpatient treatment medical equipment & supplies manufacturing patient outcomes treatment-resistant depression patient-centric care treatment for adolescents

Location

3222 Phoenixville Pike, Malvern, Pennsylvania, United States, 19355

Related Companies

Companies in the same industry